PregnantNCT03079258
Physical Activity and Vascular Health During Pregnancy
A study testing Exercise in people with Pregnant and Sedentary Lifestyle, run by Liverpool John Moores University at 1 site in United Kingdom.
Trial summary
The aim of this study is to determine the effect of aerobic exercise on maternal and offspring vascular health. Read more about this study
- Who is it for?
- Ages 18 to 45 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Pregnant, Sedentary Lifestyle
- What is being tested?
- Exercise
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 20 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 23 Apr 2017to 3 Aug 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Healthy pregnant female
- No history of cardiovascular disease, gestational diabetes or pre-eclampsia
- Single gestation
- Not on medication affecting cardiovascular health
- A non-smoker for at least 6 months
- Participating in structured exercise <twice/week
- BMI <30kg/m^2 -
Who cannot join
- Royal College of Obstetricians and Gynaecologists (RCOG) contraindications for pregnancy
- Pregnant by in-vitro fertilisation (IVF)exercise
- BMI >30kg/m^2
- >45 years old
- Structured exercise >twice/week
- Multiple gestation
Show all 9Show fewer
- Disability preventing ambulation
- Currently smoking or smoking within past 6 months prior to pregnancy
- Non-English speaking women
Trial locations and contacts
1 site in 1 country.
United Kingdom1 site
Research Institute for Sport and Exercise Sciences (RISES)
Liverpool, Merseyside, L33AF
About this study
Official title: Can Physical Activity During Pregnancy Improve Maternal and Offspring Vascular Health?
The aim of this study is to determine the effect of aerobic exercise on maternal and offspring vascular health.
Read the detailed description
The study will comprise of a randomised pilot trial to assess the effect of a moderate intensity exercise intervention on maternal and offspring vascular health. Participants will be recruited in the first trimester (T1, 10-12 weeks' gestation), and will be randomized to either a 24-week, structured and partially supervised, gym-based exercise intervention beginning in trimester 2 (T2) through to trimester 3 (T3), or a non-exercise control group who receive normal clinical care. The inclusion of this non-exercise control group is critical in allowing us to create an understanding of the adaptation of the vascular system during a normal (non-exercising) pregnancy, and also determining the physical activity and sedentary behaviour engaged in during normal healthy pregnancy. All participants will be asked to attend the laboratory at Liverpool John Moores University on 4 separate occasions synchronised with the end point of each trimester and then within four weeks of delivery. Maternal vascular health, physical activity, sedentary behaviour and fitness will be assessed during each time point throughout pregnancy while the fourth visit will comprise of an offspring vascular assessment. The investigators will also gain information on delivery outcomes including pre-term delivery, complications during labour, induction of labour, caesarean sections and post-partum haemorrhage via medical notes at the Liverpool Women's NHS Foundation Trust.
- Conditions
- Pregnant, Sedentary Lifestyle
- Being tested
- Exercise
- Keywords
- vascular structure, vascular function, cerebrovascular reactivity, physical activity, sedentary behaviour, offspring health, maternal health
- Medical subject headings
- Sedentary Behavior, Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ExerciseOther
Previously inactive pregnant women will be asked to complete 3-4 sessions of aerobic exercise each week for 24 weeks of 15-30 minutes in duration.
| Study group | Role | What they receive |
|---|---|---|
| Exercise | Experimental | Participants randomized to the exercise intervention group will be required to complete a 24-wk partially supervised exercise programme consisting of 3-4 sessions per week of 15 minutes progressing to 30 minutes over time. Receives: Other: Exercise |
| Control | No intervention | Those randomized to the control group will continue with their standard care. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Vascular Function
Vascular function will be measured via endothelial-dependent flow-mediated dilation (FMD) of the brachial and femoral arteries and reported as percentage change.
Measured: Change from baseline at week 24 and 36 of pregnancy
Secondary outcomes (3)
Change in Sedentary behaviour
Sedentary behaviour will be measured using an inclinometer at the end of each trimester for a period of 7 days in line with the accelerometer monitoring and will be reported in minutes.
Measured: Change from baseline at week 24 and 36 of pregnancy
Change in Physical activity
Physical activity will be monitored for a period of 7 days using accelerometry at the end of each trimester.
Measured: Change from baseline at week 24 and 36 of pregnancy
Incidence of Pregnancy specific outcomes
Following delivery the investigator will obtain information regarding pregnancy specific outcomes including pre-term birth, delivery complications, induction of labour, caesarean section and post-partum haemorrhage via medical notes at the collaborating hospital.
Measured: Following delivery and within 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Mar 2017
- Study start23 Apr 2017
- Primary completion30 May 2019 (estimated)
- Study completion3 Aug 2019 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for PregnantStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- This study comprises of two groups; an exercise and a control group.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 20 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Liverpool John Moores University
- Sponsor type
- University, hospital or other
- Collaborators
- Liverpool Women's NHS Foundation Trust
- Responsible party
- Principal investigator, Áine Brislane, Liverpool John Moores University
- Investigators
- Nicola Hopkins, PhD, Study director, Dr.
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03079258
- Sponsor's protocol ID
- 17/NW/0056
- Status last verified
- Feb 2019
- First submitted
- 28 Feb 2017
- Last updated
- 28 Feb 2019
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Brislane A, Jones H, Holder SM, Low DA, Hopkins ND. The Effect of Exercise During Pregnancy on Maternal and Offspring Vascular Outcomes: a Pilot Study. Reprod Sci. 2021 Feb;28(2):510-523. doi: 10.1007/s43032-020-00302-7. Epub 2020 Nov 30.
PubMed 33258064
Study at a glance
From the registry record, last updated by the sponsor on 28 Feb 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Can Physical Activity During Pregnancy Improve Maternal and Offspring Vascular Health?
- ClinicalTrials.gov ID
- NCT03079258
- Acronym / sponsor ID
- 17/NW/0056
- Conditions
- Pregnant, Sedentary Lifestyle
- Keywords
- vascular structure, vascular function, cerebrovascular reactivity, physical activity, sedentary behaviour, offspring health, maternal health
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 20 participants (estimated)
- Lead sponsor
- Liverpool John Moores UniversityUniversity, hospital or other
- Collaborators
- Liverpool Women's NHS Foundation Trust
- Study start
- 23 Apr 2017 (actual)
- Primary completion
- 30 May 2019 (estimated)
- Study completion
- 3 Aug 2019 (estimated)
- First posted
- 14 Mar 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to determine the effect of aerobic exercise on maternal and offspring vascular health.
Detailed description
The study will comprise of a randomised pilot trial to assess the effect of a moderate intensity exercise intervention on maternal and offspring vascular health. Participants will be recruited in the first trimester (T1, 10-12 weeks' gestation), and will be randomized to either a 24-week, structured and partially supervised, gym-based exercise intervention beginning in trimester 2 (T2) through to trimester 3 (T3), or a non-exercise control group who receive normal clinical care. The inclusion of this non-exercise control group is critical in allowing us to create an understanding of the adaptation of the vascular system during a normal (non-exercising) pregnancy, and also determining the physical activity and sedentary behaviour engaged in during normal healthy pregnancy. All participants will be asked to attend the laboratory at Liverpool John Moores University on 4 separate occasions synchronised with the end point of each trimester and then within four weeks of delivery. Maternal vascular health, physical activity, sedentary behaviour and fitness will be assessed during each time point throughout pregnancy while the fourth visit will comprise of an offspring vascular assessment. The investigators will also gain information on delivery outcomes including pre-term delivery, complications during labour, induction of labour, caesarean sections and post-partum haemorrhage via medical notes at the Liverpool Women's NHS Foundation Trust.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- This study comprises of two groups; an exercise and a control group.
| Arm | Type | Receives |
|---|---|---|
| Exercise | Experimental | Other: ExerciseParticipants randomized to the exercise intervention group will be required to complete a 24-wk partially supervised exercise programme consisting of 3-4 sessions per week of 15 minutes progressing to 30 minutes over time. |
| Control | No intervention | –Those randomized to the control group will continue with their standard care. |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (7 listed)
- Healthy pregnant female
- No history of cardiovascular disease, gestational diabetes or pre-eclampsia
- Single gestation
- Not on medication affecting cardiovascular health
- A non-smoker for at least 6 months
Key exclusion criteria (9 listed)
- Royal College of Obstetricians and Gynaecologists (RCOG) contraindications for pregnancy
- Pregnant by in-vitro fertilisation (IVF)exercise
- BMI >30kg/m^2
- >45 years old
- Structured exercise >twice/week
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ExercisePreviously inactive pregnant women will be asked to complete 3-4 sessions of aerobic exercise each week for 24 weeks of 15-30 minutes in duration. | Other | Exercise |
Primary outcome
Change in Vascular Function
Time frame: Change from baseline at week 24 and 36 of pregnancy
Vascular function will be measured via endothelial-dependent flow-mediated dilation (FMD) of the brachial and femoral arteries and reported as percentage change.
3 secondary outcomes
Change in Sedentary behaviour
Time frame: Change from baseline at week 24 and 36 of pregnancy
Change in Physical activity
Time frame: Change from baseline at week 24 and 36 of pregnancy
Incidence of Pregnancy specific outcomes
Time frame: Following delivery and within 4 weeks
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Feb 2019.
- Derived from this study: PubMed 33258064Brislane A, Jones H, Holder SM, Low DA, Hopkins ND. The Effect of Exercise During Pregnancy on Maternal and Offspring Vascular Outcomes: a Pilot Study. Reprod Sci. 2021 Feb;28(2):510-523. doi: 10.1007/s43032-020-00302-7. Epub 2020 Nov 30.
- Individual participant dataSharing planned: No
Related trials for Pregnant
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingObservational study
Population Pharmacokinetics of Temocillin in Acute Enterobacterial Pyelonephritis in Children
Pyelonephritis
Active, not recruitingPhase 3
A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)
Carcinoma, Renal Cell
Recruiting
Safety and Performance of UCon Patch Electrode
Urinary Incontinence, Urinary Incontinence, Urge
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Nicola Hopkins, PhD study director
Dr.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Exercise in people with Pregnant and Sedentary Lifestyle, run by Liverpool John Moores University at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 28 Feb 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Vascular Function (time frame: Change from baseline at week 24 and 36 of pregnancy). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03079258, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2019.